Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Amicus Therapeutics Inc. (FOLD)

9.35   -0.2 (-2.09%) 11-14 16:00
Open: 9.48 Pre. Close: 9.55
High: 9.575 Low: 9.33
Volume: 1,845,917 Market Cap: 2333M
Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.584 - 9.632 9.632 - 9.672
Low: 9.219 - 9.27 9.27 - 9.312
Close: 9.276 - 9.355 9.355 - 9.42

Technical analysis

as of: 2019-11-14 4:29:24 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 11.34     One year: 13.25
Support: Support1: 8.47    Support2: 7.70
Resistance: Resistance1: 9.71    Resistance2: 11.34
Pivot: 8.88
Moving Average: MA(5): 9.27     MA(20): 8.74
MA(100): 10.09     MA(250): 11.24
MACD: MACD(12,26): 0.20     Signal(9): 0.09
Stochastic oscillator: %K(14,3): 79.21     %D(3): 77.65
RSI: RSI(14): 61.64
52-week: High: 14.62  Low: 7.11  Change(%): -10.1
Average Vol(K): 3-Month: 372023  10-Days: 263776

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
FOLD has closed below upper band by 15.2%. Bollinger Bands are 18.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 22 Oct 2019 12:14:00 +0000
Is Amicus Therapeutics a Buy?

Tue, 08 Oct 2019 12:56:00 +0000
Why Amicus Therapeutics Stock Folded in September

Tue, 01 Oct 2019 13:00:00 +0000
2 Growth Stocks for In-the-Know Investors

Tue, 17 Sep 2019 12:00:00 +0000
This Company Is Looking to Win Big in Gene Therapy

Wed, 11 Sep 2019 14:23:00 +0000
Why Amicus Therapeutics Tanked in August

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 254.63
Shares Float (M) 208.00
% Held by Insiders 1.08
% Held by Institutions 104.95
Shares Short (K) 29800
Shares Short P. Month (K)

Stock Financials

EPS -2.130
Book Value (p.s.) 2.360
PEG Ratio 5.95
Profit Margin
Operating Margin -288.86
Return on Assets (ttm) -27.2
Return on Equity (ttm) -76.1
Qtrly Rev. Growth 107.1
Gross Profit (p.s.) 0.302
Sales Per Share
EBITDA (p.s.) -1.473
Qtrly Earnings Growth
Operating Cash Flow (M) -330.47
Levered Free Cash Flow (M) -199.75

Stock Valuations

P/E -4.39
P/E Growth Ratio -0.02
P/BV 3.96
P/S 14.84
P/CF -7.20

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.